$Venetoclax and decitabine in refractory TP53-mutated early T-cell precursor acute lymphoblastic leukemia$

Venetoclax and decitabine in refractory TP53-mutated early T-cell precursor acute lymphoblastic leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2022-03, Vol.101 (3), p.697-699
Hauptverfasser:	Kong, Jinyu, Chen, Nan, Li, Mengyun, Zhang, Jian, Wu, Xiaoxia, Zong, Lihong, Wu, Depei, Song, Baoquan, Qiu, Huiying
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Decitabine - therapeutic use Female Hematology Humans Letter to the Editor Medicine Medicine & Public Health Mutation - drug effects Oncology Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics Sulfonamides - therapeutic use Tumor Suppressor Protein p53 - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!